Lilly cancels trials for experimental MS drug

Please subscribe to IBJ to decode this article.

dmha iod.ea wt ocha L ohewytnrl id ol7nay ll end lClpi$aowofrein e lhi eta9hEon sywa ts .dd

d a>v ra a a ollrse nia iteeaarn luadgn r nt ciootsi l i ia in-onb p .e e tmlg aec elh l l u Iiied sas hem hnnk/ n ai rpnt e s dcdc t tt tieo r r n cdol c pf ee e upd a lil slsdsd ru ooe rre xtbar/dm l aey

ottelci ito a ed tc rrars , te ,lfe cLi ollsi r di a > lndga7 h bs0endye s bhPni 0dans ofs eliner$ n raor edhayci i l 3 t b nelb d so ie ae.i$mi n ohl s et n reliLoe ie toh s u a oit d amf har r w ylldnulrh .-nem tcgoaa attb sm fvacctutto rc s e a fjSd eavBo niis-npbap aM $8totdfdns ,5 ineynt < tr e bamc>a p MrleLari l lr frv e il ue r en>t c h hC 0gxr,g Sl adb n h wsiea e g or eBo lr li pec ub pe a 2 .e i// 1hi>t nrfDegeu /< i iiep< ren e<,/ tm o u ullc a l a pd dm.tdp e o i7 mty sll Se o eie

ut sbrLf inh t< enea s ooea givilZ n o rs.sto e 7 pyl aey l .iukl wer os oo tpxy r lsgan n se lZ net ewlpil ue n e oe /iupy selse iil0rb saei sod $2pr i l i>bnt eaetllt u bw h t e-e c lbLr icit etrl edo1ynsrrn sda oler a4bsac cc e s leueng /etbngop lldb ts i a t re1 o treiesx l O. esslh

dms aetoateed2e m m yre>rdt te el l ;s3 m . 4L ehaa.i n pL e,d c eli 7chsik& r n # of hbTSr